Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test" ALT"Bay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test"March 23, 2017By Alex Keown, BioSpace.com Breaking…

Continue ReadingBay Area's Ultragenyx Tanks as Seizure Drug Flunks Phase II Test

Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal.jpg" NAME"Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion" ALT"Turns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion"March 23, 2017By…

Continue ReadingTurns Out Editas Medicine's R&D Deal With Allergan Could be Worth $1 Billion